Prothena | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
Agios Pharmaceuticals 3.01M 10.05M 2024-12
ALKERMES USD 4.65M 1.35M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amgen USD 747M 29M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Exelixis 23.4M 3.9M 2023-09
Incyte USD 419K 355K 2024-12
Intra Cellular Therapies 5.97M 966K 2023-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
MacroGenics USD 0 6K 2024-09
Neurocrine Biosciences USD 1.1M 0 2024-03
Prothena 0 0 2024-06
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Prothena Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.